LOT 1 - 1.350 Enoxaparin Sodium 50,000 IU Injection

This tender concerns the supply of pharmaceutical products, specifically Lot 1, which involves 1,350 units of Enoxaparin Sodium 50,000 IU for injection. The procurement is detailed in accordance with Annex 1, the Material and Performance Specification. Enoxaparin sodium is an anticoagulant medication, a low molecular weight heparin (LMWH), commonly used to prevent and treat blood clots. The tender requires the provision of this specific drug in the specified quantity. Potential bidders are expected to adhere strictly to the specifications outlined in Annex 1, which will likely detail requirements regarding product quality, packaging, labeling, storage conditions, delivery timelines, and potentially manufacturer certifications or Good Manufacturing Practice (GMP) compliance. The tender is relevant for suppliers of pharmaceutical goods, particularly those specializing in anticoagulants or injectable medications. Further details regarding the scope of work, evaluation criteria, and submission deadlines will be available in the full tender documentation. Interested parties should review Annex 1 carefully to ensure they can meet all technical and logistical requirements for the supply of Enoxaparin Sodium 50,000 IU injection.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and Medical Equipment. Located in Germany, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.